This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nakayama, T. Articles by Sekine, I. Search for Related Content PubMed PubMed Citation Articles by Nakayama, T. Articles by Sekine, I.

American Journal of Pathology, Vol 149, 1931-1939, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Expression of the Ets-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasion

T Nakayama, M Ito, A Ohtsuru, S Naito, M Nakashima, JA Fagin, S Yamashita and I Sekine
Department of Pathology, Nagasaki University School of Medicine, Japan.

The proto-oncogene Ets-1 is a transcription factor known to control the expression of a number of genes involved in extracellular matrix remodeling and has been postulated to play a role in cell migration and tumor invasion. To elucidate the involvement of Ets-1 in human gastric carcinomas, we examined 11 cases of gastric adenoma and 110 cases of gastric carcinoma by immunohistochemistry and compared the degree of Ets-1 expression with the depth of carcinoma invasion. Ets-1 was not expressed either in the normal gastric epithelium or in gastric adenomas. Among the 110 cases with gastric adenocarcinoma, 70 (63.6%) showed positive staining for the Ets-1 protein. In mucosal carcinomas, only 3 of 26 cases (11.5%) showed positive immunostaining for Ets-1. In contrast, 67 of 84 cases (79.8%) with submucosal or more invasive carcinomas showed immunopositivity and intense staining for Ets-1 in the tumor cells. The pattern of Ets-1 immunostaining in mucosal carcinomas was weak and differed from that of other local invasive carcinomas (P < 0.001). Histologically, signet-ring cell and mucinous carcinomas expressed relatively weak positivity for Ets-1. Ets-1 expression correlated significantly with the presence of lymph node metastasis (P < 0.001). In situ hybridization, using an Ets-1 oligonucleotide probe, also confirmed the presence of Ets-1 mRNA in gastric carcinomas. Expression of Ets-1 mRNA was also detected in four different kinds of cultured human gastric carcinoma cell lines by the reverse transcription polymerase chain reaction method. These findings suggest that Ets-1 is overexpressed in gastric mucosal cells that have undergone malignant conversion and that Ets-1 is one of the factors involved in the penetration of gastric carcinoma beyond the muscularis mucosa.

This article has been cited by other articles:

				T. Sato and K. Furukawa Sequential Action of Ets-1 and Sp1 in the Activation of the Human beta-1,4-Galactosyltransferase V Gene Involved in Abnormal Glycosylation Characteristic of Cancer Cells J. Biol. Chem., September 21, 2007; 282(38): 27702 - 27712. [Abstract] [Full Text] [PDF]

				S. Arora, J. Kaur, C. Sharma, M. Mathur, S. Bahadur, N. K. Shukla, S. V.S. Deo, and R. Ralhan Stromelysin 3, Ets-1, and Vascular Endothelial Growth Factor Expression in Oral Precancerous and Cancerous Lesions: Correlation with Microvessel Density, Progression, and Prognosis Clin. Cancer Res., March 15, 2005; 11(6): 2272 - 2284. [Abstract] [Full Text] [PDF]

				B. Davidson, S. Konstantinovsky, S. Nielsen, H. P. Dong, A. Berner, M. Vyberg, and R. Reich Altered Expression of Metastasis-Associated and Regulatory Molecules in Effusions from Breast Cancer Patients: A Novel Model for Tumor Progression Clin. Cancer Res., November 1, 2004; 10(21): 7335 - 7346. [Abstract] [Full Text] [PDF]

				H. Yamamoto, S. Horiuchi, Y. Adachi, H. Taniguchi, K. Nosho, Y. Min, and K. Imai Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer Carcinogenesis, March 1, 2004; 25(3): 325 - 332. [Abstract] [Full Text] [PDF]

				J. Fujimoto, I. Aoki, H. Toyoki, S. Khatun, and T. Tamaya Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers Ann. Onc., October 1, 2002; 13(10): 1598 - 1604. [Abstract] [Full Text] [PDF]

				J. Fujimoto, I. Aoki, H. Toyoki, S. Khatun, and T. Tamaya Clinical implications of expression of ETS-1 related to angiogenesis in uterine endometrial cancers Ann. Onc., October 1, 2002; 13(10): 1605 - 1611. [Abstract] [Full Text] [PDF]

				B. Davidson, R. Reich, I. Goldberg, W. H. Gotlieb, J. Kopolovic, A. Berner, G. Ben-Baruch, M. Bryne, and J. M. Nesland Ets-1 Messenger RNA Expression Is a Novel Marker of Poor Survival in Ovarian Carcinoma Clin. Cancer Res., March 1, 2001; 7(3): 551 - 557. [Abstract] [Full Text]

				I. Ozaki, T. Mizuta, G. Zhao, H. Yotsumoto, T. Hara, S. Kajihara, A. Hisatomi, T. Sakai, and K. Yamamoto Involvement of the Ets-1 Gene in Overexpression of Matrilysin in Human Hepatocellular Carcinoma Cancer Res., November 1, 2000; 60(22): 6519 - 6525. [Abstract] [Full Text]

				J. Dumortier, C. Ratineau, J.-Y. Scoazec, C. Pourreyron, W. Anderson, M.-F. Jacquier, M. Blanc, C. Bernard, C. Bellaton, L. Remy, et al. Site-Specific Epithelial-Mesenchymal Interactions in Digestive Neuroendocrine Tumors : An Experimental in Vivo and inVitro Study Am. J. Pathol., February 1, 2000; 156(2): 671 - 683. [Abstract] [Full Text] [PDF]

				A. S. Takaoka, T. Yamada, M. Gotoh, Y. Kanai, K. Imai, and S. Hirohashi Cloning and Characterization of the Human beta 4-Integrin Gene Promoter and Enhancers J. Biol. Chem., December 11, 1998; 273(50): 33848 - 33855. [Abstract] [Full Text] [PDF]